Laos vs Romania: Cause of death, by non-communicable diseases, ages 15-59, female
Laos
66.7%
in 2021
Romania
67.2%
in 2021
Laos rank
71st
Romania rank
68th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Laos
- Romania
How they compare
Romania currently reports 67.2% against 66.7% in Laos, a difference of 0.5%.
Across all 6 years both countries report, Romania has been ahead every year.
Laos ranks 71st and Romania ranks 68th of 185 countries.
Romania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Laos | Romania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.2% | 83.8% | 36.6% | Romania |
| 2010s | 63.1% | 85.8% | 22.7% | Romania |
| 2020s | 69.0% | 71.5% | 2.4% | Romania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Laos or Romania?
- Romania, at 67.2% against 66.7% in Laos as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Laos and Romania?
- 0.5%, with Romania ahead.
- How many years of comparable data are there for Laos and Romania?
- 6 years are reported by both, from 2000 to 2021.
- How do Laos and Romania rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Laos ranks 71st and Romania ranks 68th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.